View Older Stories View More Recent Stories

Nov 19, 2015 04:00PM European Commission Approves Kyprolis® (carfilzomib) For Combination Use In The Treatment Of Patients With Relapsed Multiple Myeloma
Nov 16, 2015 04:00PM Amgen to Present IMLYGIC™ (Talimogene Laherparepvec) Data at the 2015 International Congress of the Society for Melanoma Research
Nov 9, 2015 05:30PM Amgen Presents Detailed Results From Phase 3 Study Demonstrating Clinical Equivalence Of Biosimilar Candidate ABP 501 With Adalimumab
Nov 8, 2015 03:45PM Amgen And Cytokinetics Announce Late-Breaking Presentation Of COSMIC-HF Trial At AHA Scientific Sessions 2015
Nov 8, 2015 03:45PM Amgen and Cytokinetics Announce Late-Breaking Presentation of COSMIC-HF Trial at AHA Scientific Sessions 2015
Nov 7, 2015 03:00PM Amgen Presents Detailed Data Comparing Etelcalcetide With Cinacalcet In Patients With Secondary Hyperparathyroidism Receiving Hemodialysis
Nov 6, 2015 04:01PM FDA Accepts Amgen's New Drug Application For Novel Intravenous Calcimimetic Etelcalcetide
Nov 5, 2015 04:01PM Amgen To Present At The Credit Suisse 24th Annual Healthcare Conference
Nov 5, 2015 09:15AM Key Data For Amgen Medicines In Relapsed Multiple Myeloma And Acute Lymphoblastic Leukemia To Be Presented At ASH 2015
Nov 4, 2015 04:01PM Amgen Highlights Data To Be Presented At 2015 American College Of Rheumatology And Association For Rheumatology Health Professionals Annual Meeting
Nov 2, 2015 04:01PM Amgen To Highlight Cardiovascular Portfolio At American Heart Association Scientific Sessions 2015
Oct 28, 2015 04:01PM Amgen's Third Quarter 2015 Revenues Increased 14 Percent To $5.7 Billion And Adjusted Earnings Per Share (EPS) Increased 18 Percent To $2.72
Oct 27, 2015 04:46PM FDA Approves IMLYGIC™ (Talimogene Laherparepvec) As First Oncolytic Viral Therapy In The US
Oct 27, 2015 08:00AM Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure
Oct 27, 2015 08:00AM Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, a Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure
Oct 23, 2015 04:01PM Amgen Announces Webcast of 2015 Third Quarter Financial Results
Oct 23, 2015 07:22AM Amgen Receives CHMP Positive Opinion For IMLYGIC™ (Talimogene Laherparepvec)
Oct 21, 2015 04:15PM Amgen Foundation Announces New $4 Million Commitment to Bring Hands-On Biotechnology Labs to Secondary School Students
Oct 14, 2015 04:18PM Amgen Announces 2015 Fourth Quarter Dividend
Oct 13, 2015 04:00PM Amgen And LabCentral Announce 2015 Golden Ticket Winners
Oct 13, 2015 09:29AM Pre-Open Stock Movers 10/13: (WPP) (PLX) (TWTR) Higher; (EOX) (HTWR) (FMC) Lower (more...)
Oct 12, 2015 04:30PM New Data Show Consistent Safety Profile For Up To 10 Years With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis
Oct 12, 2015 04:01PM New Exploratory Analysis Showed Romosozumab Increased Estimated Bone Strength More Than Teriparatide
Oct 11, 2015 06:36PM New Data Show Greater Bone Mineral Density Gains With Prolia® (Denosumab) Compared With Zoledronic Acid
Oct 6, 2015 05:06PM Amgen Announces Repatha™ Co-Preferred Position on Express Scripts National Formulary
Oct 6, 2015 09:15AM Amgen To Give 23 Presentations On Osteoporosis Disease And Treatment At American Society For Bone And Mineral Research Annual Meeting
Oct 2, 2015 04:01PM Amgen To Present At The Barclays Biosimilars Symposium
Sep 25, 2015 07:27AM Amgen Receives CHMP Positive Opinions For Two New Treatment Options For Patients With Blood Cancer In Europe
Sep 23, 2015 09:15AM Amgen To Present New Kyprolis® (carfilzomib) Data At 15th International Myeloma Workshop
Sep 23, 2015 09:00AM Amgen And Allergan Announce Positive Top-line Results From Phase 3 Study of Biosimilar Candidate ABP 215
Sep 21, 2015 12:35PM Biotechs Pressured Following Clinton Tweet (IBB)
Sep 18, 2015 04:01PM FDA Grants Priority Review for Amgen's Supplemental New Drug Application for Expanded Labeling of Kyprolis® (Carfilzomib) in Relapsed Multiple Myeloma
Sep 16, 2015 09:00AM Amgen To Acquire Privately-Held Dezima Pharma
Sep 16, 2015 07:30AM Amgen And Xencor Announce Strategic Collaboration In Cancer Immunotherapy And Inflammation
Sep 15, 2015 04:01PM Amgen To Present At The Bank Of America Merrill Lynch Global Healthcare Conference
Sep 14, 2015 09:00AM Amgen Highlights Key Clinical Data To Be Presented At European Cancer Congress 2015
Sep 11, 2015 04:01PM Amgen To Present At The Morgan Stanley Global Healthcare Conference
Sep 11, 2015 09:15AM Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)
Sep 2, 2015 04:01PM Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency
Sep 1, 2015 04:30PM Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs
Sep 1, 2015 04:01PM Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide
Aug 27, 2015 05:50PM FDA Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab)
Aug 25, 2015 09:15AM Amgen To Present New Long-Term Repatha™ (Evolocumab) Data Analysis At ESC Congress 2015
Aug 25, 2015 09:00AM Amgen Submits New Drug Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416)
Aug 18, 2015 09:00AM Amgen And University Of California, Berkeley Announce Multi-Year Partnership To Assist Cancer Patient Advocacy Organizations In Measuring Effectiveness Of Programs
Jul 30, 2015 04:05PM Amgen Announces Appointment Of Fred Hassan To Board Of Directors
Jul 30, 2015 04:01PM Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57
Jul 28, 2015 05:46PM Amgen Announces 2015 Third Quarter Dividend
Jul 27, 2015 04:01PM Amgen Announces Webcast of 2015 Second Quarter Financial Results
Jul 24, 2015 12:40PM FDA Approves Kyprolis® (carfilzomib) For Combination Use In The Treatment Of Patients With Relapsed Multiple Myeloma
View More Recent Stories View Older Stories